Martin Gnoni, MD
Infectious Disease · Louisville, KYNPI 1184983306
Payments from drug & device makers
Across 814 payments — averaging $250.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$81K
- Shionogi Inc$47K
- Paratek Pharmaceuticals, Inc.$27K
- Insmed, Inc.$19K
- La Jolla Pharmaceutical Company$17K
- Astellas Pharma US Inc$6K
- plus $6K from 20 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 192 | $81,402 |
| Shionogi Inc | 55 | $47,261 |
| Paratek Pharmaceuticals, Inc. | 99 | $27,282 |
| Insmed, Inc. | 76 | $19,391 |
| La Jolla Pharmaceutical Company | 27 | $16,884 |
| Astellas Pharma US Inc | 38 | $6,118 |
| Gilead | 123 | $1,889 |
| Viiv Healthcare Company | 91 | $1,621 |
| Merck | 62 | $1,100 |
| Melinta Therapeutics, LLC | 20 | $369 |
| Kerecis Limited | 1 | $143 |
| Smith+Nephew | 1 | $115 |
| Aimmune Therapeutics, Inc. | 5 | $102 |
| Tetraphase Pharmaceuticals, Inc. | 4 | $80 |
| Theratechnologies Inc. | 4 | $66 |
| GSK | 3 | $54 |
| Mayne Pharma Commercial LLC | 2 | $46 |
| Vyera Pharmaceuticals, LLC | 2 | $41 |
| VBI Vaccine (delaware) Inc. | 2 | $36 |
| Dynavax Technologies Corporation | 1 | $27 |
| Sanofi Pasteur Inc. | 1 | $25 |
| EMD Serono, Inc. | 1 | $25 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
| Sunovion Pharmaceuticals Inc. | 1 | $21 |
| Cumberland Pharmaceuticals, Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
How this compares
$204,154 in reported general payments places this provider in the 90th percentile of 100 infectious disease providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Louisville
- Julio RamirezLouisville$18.6M
- Forest ArnoldLouisville$4.1M
- Paul SchulzLouisville$343K
- Tariq MehmoodLouisville$75K
- Anupama RaghuramLouisville$49K
- Mark BurnsLouisville$37K
- Jeffrey ReevesLouisville$24K
- Barbara WojdaLouisville$7K
- Benjamin KlausingLouisville$7K
- Kamran AkhtarLouisville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.